Rochester General Hospital/Lipson Cancer and Blood Center is a clinical research site located in Rochester, New York, United States 14621.
Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
Rochester General Hospital/Lipson Cancer and Blood Center has participated in 2 clinical trials.
Therapeutic areas: Myelodysplastic Syndrome, Iron Overload, Triple Negative Breast Cancer.
Sponsors: Novartis Pharmaceuticals, Hoffmann-La Roche.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New York · View every site in Rochester
Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rochester General Hospital/Lipson Cancer and Blood Center has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rochester General Hospital/Lipson Cancer and Blood Center has 2 clinical trials on record. Their work covers Myelodysplastic Syndrome, Iron Overload, Triple Negative Breast Cancer.
Rochester General Hospital/Lipson Cancer and Blood Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.